$107.51
1.33[1.25%]
At close: Apr 26
$107.51
0[0.00%]
After Hours: 7:59PM EDT
Moderna
(NASDAQ:MRNA)Latest News for Moderna Stock (NASDAQ:MRNA)
Moderna Stock (NASDAQ: MRNA)
Categories: All
Thursday, April 25, 2024
- What's Going On With Pfizer Stock On Thursday?Vandana Singh - 2 days ago
- How Is The Market Feeling About Moderna?Benzinga Insights - 3 days ago
- Moderna To Present Data From Its Respiratory Portfolio, Including Vaccines And Vaccine Candidates, And Cytomegalovirus Research At ESCMID Global CongressBenzinga Newsdesk - 3 days ago
Wednesday, April 24, 2024
- Moderna Stock Jumps On Collaboration With OpenAI: What's Going On?Adam Eckert - 4 days ago
- Moderna shares are trading higher after the company and OpenAI announced a collaboration to advance mRNA medicine.Benzinga Newsdesk - 4 days ago
- Moderna And OpenAI Collaborate To Advance mRNA MedicineBenzinga Newsdesk - 4 days ago
Tuesday, April 23, 2024
Monday, April 22, 2024
- Moderna Options Trading: A Deep Dive into Market SentimentBenzinga Insights - 5 days ago
- Moderna Announced Contract With Brazil's Ministry Of Health (Ministério Da Saúde) To Supply Its mRNA Covid-19 Vaccine, Following Brazilian Health Regulatory Agency's Approval Of Its Updated Covid-19 Vaccine In March 2024Benzinga Newsdesk - 6 days ago
Wednesday, April 17, 2024
Tuesday, April 16, 2024
Friday, April 12, 2024
Thursday, April 11, 2024
- $1000 Invested In Moderna 5 Years Ago Would Be Worth This Much TodayBenzinga Insights - Apr 11, 2024, 5:30PM
- Declining COVID-19 Vaccine Sales Pinches Moderna, Pauses Kenya Vaccine Plant PlansVandana Singh - Apr 11, 2024, 11:24AM
- WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC alone, more than 4500 cases of #mpox and almost 300 deaths have been reported this year. That is triple the number reported at this time last year. The recent surge in cases and deaths among children is of particular concern, along with the re-emergence of Clade One in central Africa...."Benzinga Newsdesk - Apr 11, 2024, 10:09AM
- Needham Reiterates Hold on ModernaBenzinga Newsdesk - Apr 11, 2024, 7:38AM
- Moderna (MRNA) Up 6% on Upbeat Data From Cancer Jab StudyZacks - Apr 11, 2024, 6:45AM
- Moderna Paused Construction of mRNA Vaccine Facility in Kenya Due to Declining COVID-19 Vaccine Demand in AfricaCharles Gross - Apr 11, 2024, 6:32AM
Wednesday, April 10, 2024
Tuesday, April 09, 2024
- Why Is Moderna Stock Trading Higher On Tuesday?Vandana Singh - Apr 9, 2024, 2:16PM
- Stocks Fall Ahead Of Key Inflation Data, Gold Defends Record Highs; Bitcoin Stumbles Below $70,000: What's Driving Markets Tuesday?Piero Cingari - Apr 9, 2024, 1:53PM
- 10 Health Care Stocks With Whale Alerts In Today's SessionBenzinga Insights - Apr 9, 2024, 1:35PM
- Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Apr 9, 2024, 1:12PM
- Jefferies Reiterates Buy on Moderna, Maintains $125 Price TargetBenzinga Newsdesk - Apr 9, 2024, 12:11PM
- Moderna shares are trading higher following a poster on mRNA-4157 data in head and neck carcinoma.Benzinga Newsdesk - Apr 9, 2024, 11:13AM
- BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On TuesdayAvi Kapoor - Apr 9, 2024, 10:43AM
Friday, April 05, 2024
Thursday, April 04, 2024
- Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From JudgeVandana Singh - Apr 4, 2024, 2:32PM
- Moderna shares are trading higher as the stock rebounds after falling Wednesday. The stock dropped Wednesday after Arbutus received permission to pursue a patent claim against Moderna.Benzinga Newsdesk - Apr 4, 2024, 12:57PM
- Moderna Shares Slip Over Covid Vaccine Patent Dispute, But Chart Signals Potential Rebound AheadSurbhi Jain - Apr 4, 2024, 9:34AM
- Arbutus Biopharma Announces Claim Construction Ruling In Ongoing Patent Infringement Lawsuit Against ModernaBenzinga Newsdesk - Apr 4, 2024, 8:42AM
Wednesday, April 03, 2024
- Arbutus Stock Soars 20% As It Heads To Trial With Moderna In Covid Vaccine Patent ClaimNeil Dennis - Apr 3, 2024, 3:37PM
- Moderna shares are trading lower amid circulation of documents from an Arbutus/Genevant vs Moderna patent infringement lawsuit.Benzinga Newsdesk - Apr 3, 2024, 2:04PM
- 10 Health Care Stocks Whale Activity In Today's SessionBenzinga Insights - Apr 3, 2024, 1:35PM
- Watching Arbutus Biopharma; Traders Circulate Arbutus/Genevant Vs Moderna Patent Infringement Lawsuit Claim Construction Order Court DocumentsBenzinga Newsdesk - Apr 3, 2024, 12:22PM
Tuesday, April 02, 2024
Thursday, March 28, 2024
- 10 Health Care Stocks With Whale Alerts In Today's SessionBenzinga Insights - Mar 28, 2024, 1:35PM
- RBC Capital Reiterates Outperform on Moderna, Maintains $125 Price TargetBenzinga Newsdesk - Mar 28, 2024, 11:58AM
- A Glimpse Into The Expert Outlook On Moderna Through 5 AnalystsBenzinga Insights - Mar 28, 2024, 9:00AM
- Needham Reiterates Hold on ModernaBenzinga Newsdesk - Mar 28, 2024, 5:47AM
Wednesday, March 27, 2024
- What's Going On With Moderna Stock Wednesday?Adam Eckert - Mar 27, 2024, 8:51AM
- Moderna shares are trading higher after the company announced that MRNA-1283 met the primary endpoints in its Phase 3 clinical trial. Additionally, Blackstone Life Sciences announced it will invest up to $750 million to support Moderna's influenza program. The company will host an investor event today.Benzinga Newsdesk - Mar 27, 2024, 7:13AM
- Blackstone Invests $750 Million in Moderna's Flu Vaccine DevelopmentBenzinga Newsdesk - Mar 27, 2024, 6:38AM
- Moderna Announces Advancements in mRNA Vaccine Pipeline, Targets Major Infectious DiseasesBenzinga Newsdesk - Mar 27, 2024, 6:32AM
Tuesday, March 26, 2024
- Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia SharesBenzinga Neuro - Mar 26, 2024, 10:30PM
- Moderna's Next Gen COVID Vaccine Meets Primary Goal In Late-Stage TrialVandana Singh - Mar 26, 2024, 12:39PM
- Moderna Announces MRNA-1283 Met Primary Endpoints Of Phase 3 Clinical TrialBenzinga Newsdesk - Mar 26, 2024, 7:03AM
- Cathie Wood's Ark Ups Tesla Bet With $28M Stock Buy Amid Rebound, Also Loads Up On This Online Game PlatformShanthi Rexaline - Mar 26, 2024, 2:25AM